Skip to main content
Clinical Trials/NCT00870298
NCT00870298TerminatedNot Applicable

Randomized Controlled Study of a Computer Stop Order Versus Routine Practice When Trimethoprim/Sulfamethoxazole is Ordered Concurrently With Warfarin

University of Pennsylvania0 sites1,971 target enrollmentStarted: August 2006Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
1,971
Primary Endpoint
Reduce concomitant orders for warfarin and tmp/smx

Study Overview

Brief Summary

To determine if a computerized stop order will reduce the number of concurrent trimethoprim/sulfamethoxazole and warfarin orders accepted through the inpatient electronic ordering system while a patient is hospitalized.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Masking
Single (Participant)

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • All resident physicians and nurse practitioners involved in inpatient care.

Exclusion Criteria

  • Not provided

Arms & Interventions

computerized alert

Experimental

An automatic electronic stop of the tmp/sulfa or warfarin order whenever a resident or nurse practitioner places an order for tmp/sulfa with an already active warfarin order, or when ordering both simultaneously

Intervention: Trimethoprim/Sulfamethoxazole and Warfarin (Drug)

2 Current practice

Other

Current practice of the pharmacist recommending cessation of concurrent warfarin and tmp/sulfa orders

Intervention: Trimethoprim/Sulfamethoxazole and Warfarin (Drug)

Outcomes

Primary Outcomes

Reduce concomitant orders for warfarin and tmp/smx

Time Frame: 7 months

Secondary Outcomes

  • Determine if computerized stop order will increase risk for inadvertent cessation of warfarin(7 months)
  • Determine if computerized stop order will increase risk of delay of treatment with tmp/sulfa when determined to be necessary for treatment(7 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials